Chemokine Receptor Requirements for Epidermal T-Cell Trafficking
- 1 June 2011
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 178 (6), 2496-2503
- https://doi.org/10.1016/j.ajpath.2011.02.031
Abstract
No abstract availableKeywords
Funding Information
- Brigham and Women’s Hospital Department of Dermatology
This publication has 36 references indexed in Scilit:
- Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte traffickingNature Immunology, 2008
- Foxp3+ regulatory T cells maintain immune homeostasis in the skinThe Journal of Experimental Medicine, 2008
- Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expressionJournal of Allergy and Clinical Immunology, 2008
- Naive CD4+ T Cell Frequency Varies for Different Epitopes and Predicts Repertoire Diversity and Response MagnitudeImmunity, 2007
- Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory diseaseThe Journal of Experimental Medicine, 2007
- DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27Nature Immunology, 2007
- CCL28 Controls Immunoglobulin (Ig)A Plasma Cell Accumulation in the Lactating Mammary Gland and IgA Antibody Transfer to the NeonateThe Journal of Experimental Medicine, 2004
- Chemokines in Lymphocyte Trafficking and Intestinal ImmunityMicrocirculation, 2003
- CC Chemokine Receptor (CCR)4 and the CCR10 Ligand Cutaneous T Cell–attracting Chemokine (CTACK) in Lymphocyte Trafficking to Inflamed SkinThe Journal of Experimental Medicine, 2001
- Dispase, a Neutral Protease From Bacillus Polymyxa, Is a Powerful Fibronectinase and Type IV CollagenaseJournal of Investigative Dermatology, 1989